Citigroup’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100,800
Closed -$1.98M 6267
2022
Q2
$1.98M Buy
+100,800
New +$2.11M ﹤0.01% 2108
2021
Q4
Sell
-93,500
Closed -$2.44M 6066
2021
Q3
$2.44M Buy
+93,500
New +$2.26M ﹤0.01% 2370

Other funds holding SHC

Citigroup's SHC Position: Q1 2026 in Review

Citigroup increased its Sotera Health (SHC) stake by 35% in Q1 2026, buying an estimated $495K and bringing the position to 115,349 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

Citigroup first reported a position in SHC in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.74M in Q1 2022. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • Citigroup held 115,349 shares of Sotera Health worth $1.65M as of Q1 2026.
  • Citigroup bought 29,811 Sotera Health shares in Q1 2026, an estimated $495K.
  • Sotera Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2794 holding.
  • Citigroup first reported a position in Sotera Health in Q4 2020 and has held it in 22 quarters since.
  • Citigroup's Sotera Health position peaked at $1.74M in Q1 2022.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.